Infertility: Clinical Trials

263 trials for Infertility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

158 completed, 44 unknown, 20 recruiting, 17 terminated. 263 Phase 3, 57 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3263Completed 158, Unknown 44, Recruiting 20, Terminated 17, Withdrawn 10, Active not recruiting 6, Not yet recruiting 6, Suspended 2
Phase 257Completed 30, Unknown 9, Recruiting 8, Terminated 5, Withdrawn 4, Suspended 1

Follow Infertility: new trials by email Literature Review of Infertility trials Research Report on Infertility

Trials (filtered) newest first · largest first

All 263 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Study of Post-Varicocelectomy Myo-inositol vs. Antioxidants vs. Surgery Alone in Infertile Men
Experimental Arm Intervention: Myo-inositol, Conventional Antioxidants, Group C (Control) - Myo-inositol, Post Varicocelectomy
Phase 3Not yet recruitingFayoum University Hospital1502026-10-262026-11-04
Intrauterine G-CSF Infusion for Thin Endometrium
Granulocyte Colony-Stimulating Factor(G-CSF), Normal Saline - Thin Endometrium, Female Infertility
Phase 3Not yet recruitingNanjing University6202026-10-012026-07-09
Uterine Transplant in Absolute Uterine Infertility (AUIF)
Uterine Transplant - Female Infertility
Phase 2 / Phase 3WithdrawnBrigham and Women's Hospital2026-09-012026-10-15
Progesterone Luteal Support in Unexplained Infertility Management
Utrogestan® 200 mg Soft Capsule, Placebo soft capsule 200 mg - Infertility, Female Infertility
Phase 3Not yet recruitingSimone Broer6402026-08-012026-07-30
150 IU vs. 225 IU FSH in Normal Responders: The OPTIMAL-DOSE Trial
Follicle-stimulating hormone (FSH) - Infertility, Female
Phase 3WithdrawnAmerican Hospital 2 Kosovo2026-03-012026-10-29
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Follitropin alfa/lutropin alfa (MBJ-0011), hMG, Cetrorelix acetate - Infertility
Phase 3RecruitingMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2662026-02-052026-10-29
hCG Priming in Women With Diminished Ovarian Reserve
Choriongonadotropin alfa (hCG), Isotonic NaCl (Placebo) - Infertility, Female, Ovarian Reserve
Phase 3RecruitingKristine Loessl802026-01-252026-09-21
Testing Herbal Pretreatment For IVF Success In Women With Low Ovarian Reserve
Bushen Tongzhi Formula, Placebo Pretreatment plus Standard IVF/ICSI - Diminished Ovarian Reserve (DOR)
Phase 3Not yet recruitingPeking Union Medical College Hospital3482026-01-012026-01-16
Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells
Clomifene Citrate, Placebo - Azoospermia, Nonobstructive
Phase 3WithdrawnHospices Civils de Lyon2026-01-012026-06-17
Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men
L-carnitine - Oligoasthenozoospermia, Male Infertility
Phase 3Active not recruitingSouth Valley University502026-01-012026-02-11
Clinical Evaluation of Integrated Chinese-Western Medicine for Infertility With DOR Patients in Women Achieving Natural Pregnancy
Western Medicine, Traditional Chinese Medicine, Placebo - Diminished Ovarian Reserve (DOR), Infertility
Phase 3Not yet recruitingPeking Union Medical College Hospital3202025-12-252025-12-22
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
hMG subcutaneous injection, Placebo - Infertility (IVF Patients)
Phase 3Active not recruitingGranata Bio Corporation6592025-11-012026-11-05
PKB171 Against Placebo in Couples With Mild Male Factor Infertility
Intravaginal gel, Vaginal Gel with Applicator - Infertility Due to Azoospermia
Phase 2 / Phase 3RecruitingProkrea BCN, S.L.7322025-10-282026-06-25
Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization
Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day., DHEA plus folic acid 400mcg per day, control group - Infertility, Infertility (IVF Patients)
Phase 2 / Phase 3RecruitingBeni-Suef University1652025-10-102026-01-07
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
embryo transfer - Infertility (IVF Patients)
Phase 3RecruitingBeth Israel Deaconess Medical Center11262025-09-102026-04-02
Fertilo In Vitro Research Study and Trial
Fertilo, Medicult IVM - In Vitro Maturation of Oocytes
Phase 3RecruitingGameto, Inc.5002025-04-172026-10-07
Progesterone-modified Natural Cycle for FET
Progesterone-modified natural cycle preparation for frozen embryo transfer, Hormone replacement therapy cycle preparation for frozen embryo transfer - Infertility, Female
Phase 3RecruitingShandong University of Traditional Chinese Medicine3362025-03-052026-04-29
Lidocaine Prilocaine Spray in Reducing Pain During Hysterosalpingography in Women With Primary Infertility
EMLA SPRAY, Placebo - Infertility, Female
Phase 3Not yet recruitingCairo University902025-02-102025-01-10
Inositol in Letrozol Resistant PCOS Women
Myoinositol, Metformin - Polycystic Ovary Syndrome, Infertility
Phase 2 / Phase 3CompletedKafrelsheikh University1362024-04-102026-09-29
Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females
Alpha lipoic acid, Letrozole - Polycystic Ovary Syndrome, Infertility, Female
Phase 3CompletedAin Shams University1502024-04-012026-09-16

Showing 20 of 263. Sign in to see all of them.

Narrower conditions

Infertility, Female (53)  ·  Infertility, Male (20)  ·  Polycystic Ovary Syndrome (18)  ·  Helping Behavior (7)  ·  Obesity (6)  ·  Endometriosis (5)  ·  Oligospermia (5)  ·  Anovulation (3)  ·  Asthenozoospermia (3)  ·  Breast Neoplasms (3)  ·  Endometrial Hyperplasia (3)  ·  Abortion, Spontaneous (2)  ·  Adenomyosis (2)  ·  Azoospermia, Nonobstructive (2)

Broader conditions

Genital Diseases (263)  ·  Urogenital Diseases (263)  ·  Female Urogenital Diseases and Pregnancy Complications (80)  ·  Female Urogenital Diseases (78)  ·  Genital Diseases, Female (76)  ·  Male Urogenital Diseases (27)  ·  Genital Diseases, Male (25)  ·  Endocrine System Diseases (24)  ·  Neoplasms (24)  ·  Gonadal Disorders (22)  ·  Adnexal Diseases (19)  ·  Ovarian Diseases (19)  ·  Cysts (18)  ·  Ovarian Cysts (18)

Interventions

follitropin alfa (24)  ·  Letrozole (18)  ·  Clomiphene (16)  ·  Gonadotropin-Releasing Hormone (14)  ·  Chorionic Gonadotropin (12)  ·  Progesterone (10)  ·  Triptorelin Pamoate (9)  ·  follitropin beta (9)  ·  Dehydroepiandrosterone (8)  ·  FE 999049 (8)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (8)  ·  follitropin delta (8)  ·  ganirelix (8)  ·  Glycoprotein Hormones, alpha Subunit (6)  ·  Injections (6)

Sponsors

Cairo University (19)  ·  Royan Institute (17)  ·  Ferring Pharmaceuticals (15)  ·  Benha University (8)  ·  Merck KGaA, Darmstadt, Germany (8)  ·  IBSA Institut Biochimique SA (7)  ·  Yale University (7)  ·  Assiut University (6)  ·  Organon and Co (6)  ·  Universitair Ziekenhuis Brussel (5)  ·  Genesis Athens Clinic (4)  ·  Beni-Suef University (3)  ·  Catalysis SL (3)  ·  Forest Laboratories (3)  ·  Instituto de Investigacion Sanitaria La Fe (3)

Countries

Egypt (40)  ·  United States (34)  ·  Iran (21)  ·  China (20)  ·  Spain (19)  ·  Belgium (16)  ·  Denmark (14)  ·  France (14)  ·  Italy (11)  ·  Canada (9)  ·  United Kingdom (9)  ·  Germany (8)  ·  Greece (8)  ·  Switzerland (7)  ·  Austria (6)

Top investigators

Hamid Gourabi, PhD (10)  ·  Nanette Santoro, MD (7)  ·  Tahereh Madani, MD (7)  ·  Heping Zhang, PhD (6)  ·  Esther Eisenberg, MD, MPH (4)  ·  Michael Diamond, MD (4)  ·  Richard Legro, MD (4)  ·  Christos Coutifaris, MD (3)  ·  Ernest HY Ng, MD (3)  ·  Peter Casson, MD (3)  ·  Robert Brzyski, MD, PhD (3)

Results publications

PMID 26991902, PMID 26354094, PMID 26950065, PMID 35506389, PMID 21645894, PMID 25324541, PMID 26413816, PMID 27402910, PMID 27619773, PMID 29102040, PMID 29778387, PMID 30085176, PMID 30801744, PMID 33190149, PMID 33534895, PMID 33851429, PMID 34110001, PMID 34180998, PMID 34254211, PMID 34792133, PMID 34799275, PMID 35125179, PMID 36165742, PMID 37156263, PMID 37699851, PMID 39672366, PMID 40714031, PMID 11527911, PMID 11756355, PMID 14581508, PMID 14688154, PMID 15465836, PMID 15640258, PMID 16174713, PMID 17022858, PMID 17287476, PMID 17376819, PMID 17636251, PMID 17980364, PMID 18000088, PMID 18068166, PMID 18074014, PMID 18230195, PMID 18364705, PMID 18487215, PMID 18675974, PMID 19056992, PMID 19131401, PMID 19509098, PMID 19684043

NIH funding

2015 (3), 2004 (2), 2014 (2), 2017 (2), U10HD055925 (2), 2023 (1), 2025 (1), R01AA014678 (1), R01HD100336 (1), U01HD038997 (1), U10CA037429 (1), U10HD039005 (1), U10HD055936 (1)